Levetiracetam Bluefish (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. By stabilising neuronal firing and decreasing excessive excitability, the drug lowers the likelihood of seizure initiation and spread throughout the brain.

The appropriate dose of Levetiracetam Bluefish is determined by the prescribing clinician based on the patient’s age, weight, renal function, seizure type, and response to therapy. Dosage adjustments are made individually and are not standardized in public information.

Levetiracetam is classified as Pregnancy Category B, indicating that animal studies have not shown risk and there are no adequate human studies. It may be used during pregnancy only if the potential benefit outweighs any risk. Limited data suggest it is excreted in breast milk, so breastfeeding decisions should be made with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Levetiracetam Bluefish. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any required temperature control), and import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancers such as valproate. It generally has fewer drug‑enzyme interactions, a relatively favourable side‑effect profile, and can be used as monotherapy or adjunctive therapy, making it a versatile option in many treatment regimens.

Store Levetiracetam Bluefish at temperatures below 25 °C (77 °F). Keep the product in its original container, protect it from moisture and direct sunlight, and avoid freezing. These conditions help maintain the tablet’s stability and potency throughout its shelf life.

Levetiracetam Bluefish is taken orally. The tablets should be swallowed whole with a glass of water and may be taken with or without food. Patients should follow the dosing schedule prescribed by their healthcare provider and not alter the regimen without medical advice.

Serious risks include severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome, emergence of suicidal thoughts or depressive symptoms, and rare blood disorders like neutropenia. Any signs of rash, mood changes, or unusual bleeding should prompt immediate medical evaluation.

Levetiracetam Bluefish is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is advised for patients with severe renal impairment, uncontrolled psychiatric illness, or those taking medications that may significantly reduce its efficacy without appropriate monitoring.